New mutation in ParE in a pneumococcal in vitro mutant resistant to fluoroquinolones

被引:18
作者
Janoir, C
Varon, E
Kitzis, MD
Gutmann, L
机构
[1] Univ Paris 06, LRMA, F-75270 Paris 06, France
[2] Hop St Joseph, Serv Bacteriol, F-75674 Paris, France
关键词
D O I
10.1128/AAC.45.3.952-955.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
For an in vitro mutant of Streptococcus pneumoniae selected on moxifloxacin four- to eightfold-increased MICs of new fluoroquinolones, only a twofold-increased MIC of ciprofloxacin, and a twofold-decreased MIC of novobiocin were observed. This phenotype was conferred by two mutations: Ser81Phe in GyrA and a novel undescribed His103Tyr mutation in ParE, outside the quinolone resistance-determining region, in the putative ATP-binding site of topoisomerase IV.
引用
收藏
页码:952 / 955
页数:4
相关论文
共 31 条
  • [1] THE 43-KILODALTON N-TERMINAL FRAGMENT OF THE DNA GYRASE-B PROTEIN HYDROLYZES ATP AND BINDS COUMARIN DRUGS
    ALI, JA
    JACKSON, AP
    HOWELLS, AJ
    MAXWELL, A
    [J]. BIOCHEMISTRY, 1993, 32 (10) : 2717 - 2724
  • [2] Engineering the specificity of antibacterial fluoroquinolones:: Benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase
    Alovero, FL
    Pan, XS
    Morris, JE
    Manzo, RH
    Fisher, LM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 320 - 325
  • [3] Molecular characterization of the gene encoding the DNA gyrase a subunit of Streptococcus pneumoniae
    Balas, D
    Fernández-Moreira, E
    De la Campa, AG
    [J]. JOURNAL OF BACTERIOLOGY, 1998, 180 (11) : 2854 - 2861
  • [4] Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae
    Baranova, NN
    Neyfakh, AA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1396 - 1398
  • [5] Structure and mechanism of DNA topoisomerase II
    Berger, JM
    Gamblin, SJ
    Harrison, SC
    Wang, JC
    [J]. NATURE, 1996, 379 (6562) : 225 - 232
  • [6] BERNARD L, 1994, CLIN MICROBIOL INFEC, V1, P60
  • [7] Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae
    Brenwald, NP
    Gill, MJ
    Wise, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2032 - 2035
  • [8] Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center
    Brino, L
    Urzhumtsev, A
    Mousli, M
    Bronner, C
    Mitschler, A
    Oudet, P
    Moras, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) : 9468 - 9475
  • [9] Crystal structure of the breakage-reunion domain of DNA gyrase
    Cabral, JHM
    Jackson, AP
    Smith, CV
    Shikotra, N
    Maxwell, A
    Liddington, RC
    [J]. NATURE, 1997, 388 (6645) : 903 - 906
  • [10] CONTRERAS A, 1992, MOL MICROBIOL, V6, P1617